These results further supported a critical role of the FoxM1/ADAM17/EGFR pathway in promoting tumor progression of human glioblastoma, implicating that FoxM1/ADAM17 axis might involve in tumorigenicity of glioma cells in vivo. This evidence concerns the gene FOXM1 and glioblastoma.